Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue October 2015
 •  MAC X Zac Posen for Spring 2016  •  L'Oréal USA Unveils Women in Science Honorees  •  Global Handwashing Day is Oct. 15  •  Oral Care Kit Recall  •  Algenist Rolls Out Lip Balm With SPF 15

Symrise Takes Stake in U.S. BioTech Firm

Published October 7, 2008
Post a comment
Symrise has acquired a 20% stake Therapeutic Peptides Inc. (TPI), a New Orleans, LA-based biotechnology company, giving it exclusive distribution rights for advanced cosmetic active ingredients, including peptides.

“We are delighted to be able to integrate these modern and very effective ingredients in our portfolio. With TPI, we have found a partner who is developing these ingredients at a scientifically exalted level and can offer ample expertise in this field,” said Dr. Klaus Stanzl, president, scent and care, Life Essentials.

More info: www.symrise.com

blog comments powered by Disqus